UMass Medical School immunologist Katherine Luzuriaga, MD, has been named to the list of Foreign Policy’s 100 Leading Global Thinkers of 2013 for “bringing the world closer to a cure for HIV.”
Nathan Mehlhouse was diagnosed with autism at age 5 and has shown significant progress since his parents began taking him to UMass Medical School’s Center for Autism and Neurodevelopmental Disorders (CANDO) Clinic, which was the beneficiary of the Fund-A-Need auction at the 2013 Winter Ball on Dec. 6.
In a rare public speech, Jan Cellucci said her late husband Paul, the former Massachusetts governor and U.S. ambassador to Canada, hoped his campaign to fund a cure for ALS wouldn’t end with his death from the disease.
The dramatic reports of a recent study concluding that delirium leads to lingering cognitive impairments in three out of four patients hospitalized in an intensive care unit are consistent with findings from similar research conducted at UMass Medical School by neuroepidemiologist Jane Saczynski, PhD.
UMass Medical School’s MassBiologics has received an orphan drug designation from the U.S. Food and Drug Administration for MBL-HCV1, a monoclonal antibody developed to prevent the recurrence of hepatitis C virus in patients receiving a liver transplant.
Jun R. Huh, PhD, assistant professor of medicine in the Division of Infectious Diseases & Immunology, received the 2013 Smith Family Foundation Award for Excellence in Biomedical Research, a highly competitive award intended to help launch the careers of newly independent biomedical researchers.
UMMS RNA expert Melissa J. Moore, PhD, and Harvard Medical School’s Ananth Karumanchi, MD, recently received a $1 million grant from the Bill & Melissa Gates Foundation to develop a novel, RNA-based therapy for preeclampsia.
Autism researcher Teresa Mitchell, PhD, comments on a recent study that found autism spectrum disorder indicators might begin to show up in infants as young as 2 months old.